Sun Pharmaceutical Industries Share Price, NSE #pharma #group

Posted On May 17 2017 by

#sun pharma # Stock Price Quotes Sun Pharmaceutical Industries Ltd. Sun Pharmaceutical Industries Ltd. Sun Pharmaceutical Industries Ltd. incorporated in the year 1993, is a Large Cap company (having a market cap of Rs 188,232.23 Cr.) operating in Pharmaceuticals and health care sector. Sun Pharmaceutical Industries Ltd. key Products/Revenue Segments include Formulations which contributed Rs 5869.69 Cr to Sales Value (75.78% of Total Sales), Bulk Drugs which contributed Rs 1327.80 Cr to Sales Value (17.14% of Total Sales), Other Operating Revenue which contributed Rs 482.43 Cr to Sales Value (6.22% of Total Sales), Others which contributed Rs 64.97 Cr to …


Sun Pharma to buy Dusa for $230 million #naveh #pharma

Posted On May 13 2017 by

#dusa pharma # Sun Pharma to buy Dusa for $230 million Updated: Thu, Nov 08 2012. 11 43 PM IST Mumbai: Sun Pharmaceuticals Industries Ltd. India s most valuable drug maker, has agreed to buy US-based skincare speciality company DUSA Pharmaceuticals Inc. for $230 million ( Rs. 1,251 crore). Under the terms of the agreement, a subsidiary of Sun Pharma will commence a tender offer for all outstanding common stock of DUSA at a price of $8 per share in cash, a 38% premium to the closing price on 7 November, the Indian company said on Thursday. The transaction has …


Sun joins dermatology rush with $230M DUSA buyout #pharma #supply #chain

Posted On May 13 2017 by

#dusa pharma # Sun joins dermatology rush with $230M DUSA buyout Dermatology is hot. Valeant Pharmaceuticals ($VRX) has been snapping up skin-remedy companies, including its recent $2.6 billion deal for Medicis. Novartis’ generics unit Sandoz agreed in May to buy U.S.-based Fougera Pharmaceuticals, to become the biggest player in dermatology generics. Now, India-based Sun Pharmaceutical is joining the party. It’s buying U.S. drugmaker DUSA Pharmaceuticals for about $230 million, or $8 per share, a 38% premium to yesterday’s closing price. The key prizes: DUSA’s Levulan combination therapy, used to treat non-hyperkeratotic actinic keratoses, and BLU-U, used to treat acne. “DUSA …


Sun Pharma to acquire US dermatology company DUSA Pharma #astellas #pharma #inc

Posted On May 13 2017 by

#dusa pharma # Sun Pharma to acquire US dermatology company DUSA Pharma (Under the terms of the agreement, ) AHMEDABAD: Mumbai-based Sun Pharmaceutical Industries Ltd is set to acquire US-based DUSA Pharmaceuticals, Inc, a dermatology company focused on developing and marketing its Levulan (aminolevulinic acid HCl) photodynamic therapy platform. The two companies entered into a definitive agreement. Under the terms of the agreement, a 100% subsidiary of Sun Pharmaceutical Industries Ltd will commence a tender offer for all of the outstanding common stock of DUSA at a price of $8.00 per share in cash, a 38% premium to the closing …


Sun Pharma bets on new products to boost US skincare items rise #dey #pharma

Posted On May 12 2017 by

#sun pharma products # Jun 23, 2016, 05.48 PM | Source: Reuters Sun Pharma bets on new products to boost US skincare items rise The world’s fifth-largest maker of generic drugs was the first among its Indian peers to enter the roughly USD 5 billion US dermatology space by acquiring a controlling stake in Israel’s Taro Pharmaceutical Industries Ltd in 2010. Like this story, share it with millions of investors on M3 Sun Pharma bets on new products to boost US skincare items rise The world’s fifth-largest maker of generic drugs was the first among its Indian peers to enter …


Sun Pharma MD Dilip Shanghvi expects own products in 2-3 years #jobs #in #pharmaceutical #industry

Posted On May 12 2017 by

#sun pharma products # Sun Pharma MD Dilip Shanghvi expects own products in 2-3 years BS Reporter | Hyderabad Jul 30, 2015 06:54 PM IST Sun Pharmaceutical Industries Limited managing director Dilip Shanghvi today said he expects to have their own innovative products registered in the next 2-3 years in the US and that moment would also validate his belief that one need not spend $2.5 billion in research to develop a new product. Sun Pharma Advanced Research Company (Sparc), which was created over eight years ago by Sun Pharma by spinning off its research activity, has its 3 innovative …


Sun Pharmaceutical Sdn Bhd #jobs #in #pharmaceutical #industry

Posted On May 12 2017 by

#sun pharma products # Welcome to Sun Pharmaceutical Find out more about our products in heart management, skin and hair management, pain management, microcirculation management, energy power, mental performance, bone & muscle management and our reproduction function medicine product line. Sun Pharmaceutical is driven by a strong set of core values and work ethics, people-centric and conducts a variety of community-based public forums and education campaigns as part of our CSR (Corporate Social Responsibility). We also conduct some R D (research and development) activities and hosts medical talks and seminars. Research Development Copyright � 2011 – 2013 Sun Pharmaceutical Sdn …


FDA bans imports from Sun Pharma plant in India crackdown #sandoz #pharma

Posted On May 1 2017 by

#sun pharma # FDA bans imports from Sun Pharma plant in India crackdown By Zeba Siddiqui and Sumeet Chatterjee | MUMBAI MUMBAI (Reuters) – The U.S. Food and Drug Administration (FDA) has banned imports from Indian generic drugmaker Sun Pharmaceutical Industries Ltd’s plant at Karkhadi in the western state of Gujarat, in the latest quality blow for India’s drug sector. The FDA has imposed a rash of regulatory sanctions on Indian generic makers in the last year, triggering concerns about the quality of the medicines supplied by the $14 billion industry to countries including the United States, the biggest market. …


Sun Pharma Industries on the Forbes World’s Most Innovative Companies List #biotech #pharma #jobs

Posted On May 1 2017 by

#sun pharma # #73 Sun Pharma Industries Market Cap As of May 2016 $29.7 Billion Industry Pharmaceuticals Country India Chief Executive Officer Dilip Shanghvi Website http://www.sunpharma.com Employees 30 000 Sales $4.13 B Sun Pharmaceutical Industries Ltd. manufactures and markets pharmaceutical ingredients. The company manufactures and markets a basket of pharmaceutical formulations as branded generics as well as generics in India, the United States and several other markets across the world. Sun Pharmaceutical engages in product development, process chemistry, and manufacturing of complex API, as well as dosage forms. Its products are prescribed in chronic therapy areas like cardiology, psychiatry, neurology, …


Sun Pharma inks pact to buy DUSA for $230 million – The Hindu #generic #drug #industry

Posted On Apr 27 2017 by

#dusa pharma # Sun Pharma inks pact to buy DUSA for $230 million Sun Pharmaceutical Industries, on Thursday, said it had inked a pact to acquire U.S.-based DUSA Pharmaceuticals for around $230 million (about Rs.1,250 crore). Sun Pharma and DUSA Pharmaceuticals have entered into a definitive agreement under which Sun Pharma will acquire DUSA, a dermatology company focused on developing and marketing its Levulan photo-dynamic therapy platform, Sun Pharma said in a statement. Under the terms of the agreement, a 100 per cent subsidiary of Sun Pharma will commence a tender offer for all of the outstanding common stock of …